| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317267 | Clinical Biochemistry | 2015 | 7 Pages |
Abstract
Plasma IGFBP-4-fragment levels are not acutely altered in patients with STEMI treated with UFH and PCI. Thus, they possess potentials as prognostic markers in ACS patients.
Keywords
TR-IFMACarboxy terminalUFHLMWHVSMCGAGIGF-IPCIkDaACSNSBSTEMIcpsMACEIGF-IRIGFBPST-segment elevation myocardial infarction (STEMI)PBSPAPP-AMyocardial infarctionnon-specific bindingECGelectrocardiogramstandard deviationrecombinant humaninsulin-like growth factor IST-segment elevation myocardial infarctioncardiovascular diseaseBiomarkeramino terminalTime-resolved immunofluorometric assaymajor adverse cardiac eventsVascular smooth muscle cellsAcute coronary syndrome (ACS)Acute coronary syndromecounts per secondconfidence intervalInsulin-like growth factor (IGF)Phosphate buffered salineLADpercutaneous coronary interventionHeparinLow molecular weight heparinunfractionated heparinPregnancy-associated plasma protein Ainsulin-like growth factor binding proteinleft anterior descendingKilo DaltonGlycosaminoglycanInsulin-like growth factor I receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Rikke Hjortebjerg, Søren Lindberg, Søren Hoffmann, Jan S. Jensen, Claus Oxvig, Mette Bjerre, Jan Frystyk,